Cipla cuts prices on 3 anti-cancer drugs: reports

India Infoline News Service | Mumbai |

Reports stated that these drugs are for the treatment of lung and pancreatic cancer, breast cancer, head & neck cancer, gastric cancer, bladder, colorectal and colon cancers.

Drug maker Cipla has reduced the prices on three anti-cancer drugs — Erlotinib (ERLOCIP), Docetaxel (DOCETAX) and Capecitabine (CAPEGARD), according to reports.

Reports stated that these drugs are for the treatment of lung and pancreatic cancer, breast cancer, head & neck cancer, gastric cancer, bladder, colorectal and colon cancers.

BSE 473.65 6.05 (1.29%)
NSE 473.45 5.50 (1.18%)

***Note: This is a NSE Chart